Biovax Director Wangoro Mwangi Calls on Kenyans in U.S. to Invest in Kenya

Biovax Director Wangoro Mwangi has urged Kenyans living in the United States to channel their resources and expertise back into Kenya, highlighting that diaspora investment is crucial for building a stronger national economy.

Speaking during his U.S. tour, Mwangi emphasized that Kenyans abroad hold untapped potential that could transform key sectors such as healthcare, manufacturing, housing, and technology.

“If each of us committed to one project, however small, we would collectively transform Kenya’s economy,” he said.

Mwangi pointed to initiatives like Biovax, which focuses on vaccine production and pharmaceutical research, as evidence of Kenya’s growing capacity to lead in innovation and health security.

He encouraged diaspora Kenyans to partner with local businesses and government programs to create jobs and improve livelihoods.

Earlier, PS Medical Services Dr. Ouma Oluga made a case to American investors to consider partnering with the government and investing in the Kenya BioVax Institute Limited, one of the first of its kind in the region.

Speaking at an event organized by Kenya Vision 2030 at the Dalberg offices in Washington, D.C., Dr. Oluga highlighted the government’s efforts in establishing infrastructure and staffing for the institute, urging investors to join early to leverage the ready market and guaranteed returns.

“Investors can benefit from incentives such as tax relief and duty exemptions on medical-related supplies and equipment,” he noted.

At the same event, Ag. Biovax CEO Dr. Cecelia Wanjala highlighted Africa’s enormous vaccine demand, estimated at 300 million doses annually, of which only one per cent is currently manufactured on the continent.

She said this gap represents a huge investment opportunity for partners willing to engage with Biovax.